We measured the viscosity of poly(ethylene glycol) (PEG 6000, 12 000, 20 000) in water using capillary electrophoresis and fluorescence correlation spectroscopy with nanoscopic probes of different diameters (from 1.7 to 114 nm). For a probe of diameter smaller than the radius of gyration of PEG (e.g.rhodamine B or lyzozyme) the measured nanoviscosity was orders of magnitude smaller than the macroviscosity. For sizes equal to (or larger than) the polymer radius of gyration, macroscopic value of viscosity was measured. A mathematical relation for macro and nanoviscosity was found as a function of PEG radius of gyration, Rg, correlation length in semi-dilute solution, ξ, and probe size, R. For R < Rg, the nanoviscosity (normalized by water viscosity) is given by exp(b(R/ξ)a), and for R > Rg, both nano and macroviscosity follow the same curve, exp(b(R/ξ)a), where a and b are two constants close to unity. This mathematical relation was shown to equally well describe rhodamine (of size 1.7 nm) in PEG 20 000 and the macroviscosity of PEG 8 000 000, whose radius of gyration exceeds 200 nm. Additionally, for the smallest probes (rhodamine B and lysozyme) we have verified, using capillary electrophoresis and fluorescence correlation spectroscopy, that the Stokes–Einstein (SE) relation holds, providing that we use a size-dependent viscosity in the formula. The SE relation is correct even in PEG solutions of very high viscosity (three orders of magnitude larger than that of water).
Neurodegenerative diseases (NDs) are a diverse group of disorders characterized by the progressive degeneration and death of neurons, leading to a range of neurological symptoms. Despite the heterogeneity of these conditions, a common denominator is the implication of mitochondrial dysfunction in their pathogenesis. Mitochondria play a crucial role in creating biomolecules, providing energy through adenosine triphosphate (ATP) generated by oxidative phosphorylation (OXPHOS), and producing reactive oxygen species (ROS). When they’re not functioning correctly, becoming fragmented and losing their membrane potential, they contribute to these diseases. In this review, we explore how mitochondria fuse and undergo fission, especially in the context of NDs. We discuss the genetic and protein mutations linked to these diseases and how they impact mitochondrial dynamics. We also look at the key regulatory proteins in fusion (MFN1, MFN2, and OPA1) and fission (DRP1 and FIS1), including their post-translational modifications. Furthermore, we highlight potential drugs that can influence mitochondrial dynamics. By unpacking these complex processes, we aim to direct research towards treatments that can improve life quality for people with these challenging conditions.
25 August 2011 in The Journal of Physical Chemistry C
Controlled formation of gene delivery complexes (DNA and a vector, usually a cationic polymer) is one of the key challenges in developing efficient gene delivery systems. The researchers focused their procedures on the ratio of vector to DNA, neglecting the influence of concentration on the complex formation process. In this study we show, by studying the association of polyethylenimine (PEI) and 66-base pair (bp) DNA fragments, that the concentration of the gene delivery system greatly influences the formation of PEI/DNA complexes even at a fixed PEI/DNA ratio. We find that the charge and the size of PEI/DNA complexes are increasing functions of their concentration even in a highly dilute regime of concentrations. The number of PEI/DNA molecules in a complex was calculated from the measured charge and electrophoretic mobility. We established a model, on the basis of Smoluchowski theory, to explain the relation between the concentration and the size of PEI/DNA complexes. We analyzed the structure of the complexes and found out that a large proportion of space in the PEI/DNA complexes is occupied by the solvent. This study indicates that the influence of concentration should be seriously considered in gene delivery studies, since large PEI/DNA complexes can be prepared by scaling up their concentration simultaneously without increasing the dosage of PEI.